hTERT promoter has been used in directing therapeutic gene expression such as E1A, showing a high specificity towards CRC, inhibiting 75% of cancer cell growth, obtaining apoptosis and necrosis levels of 32.3 and 31.5% respectively (71). The gene discussed is DHTKD1; the disease is colorectal carcinoma.